Curis | CRIS - Операционный доход





Операционный доход Изменить Дата
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
CSL USD 2.64B 1.97B 2025-12
Curis USD -7.88M 4.63M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Incyte USD 383.88M 47.43M 2025-12
Merck USD 6.24B 318M 2025-12
Novartis USD 4.06B 437M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Takeda JPY 168.82B 479.89B 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12
Verastem USD -41.48M 23.2M 2025-12
Xoma USD -15.64M 5.56M 2024-09